학술논문
Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial
Document Type
Article
Author
Source
In Blood Advances 23 May 2023 7(10):2008-2017
Subject
Language
ISSN
2473-9529